HYDERABAD: Dr Bhumika Reddy, a young and upcoming medical professional, gave a new lease of life to five individuals after ...

Dr. Reddy's Laboratories Ltd. closed 12.64% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

Dr. Reddy's (RDY) partners with Shanghai Henlius Biotech to develop and market biosimilar versions of J&J's (JNJ) multiple ...

HYDERABAD: Dr Reddy’s Laboratories SA, the wholly-owned Swiss subsidiary of Hyderabad-based pharma biggie Dr Reddy’s ...

Hyderabad: The Telangana state Director General of Police Dr Jitender emphasised the need for essential reforms in the police ...

Dr. K. Subba Reddy, Sr. Consultant and HOD, Department of Critical Care Medicine, Apollo Health City shares how home-cooked ...

Telangana Chief Minister Revanth Reddy discussed the state's investment progress. He aims for projects worth Rs 1 lakh crore this year, highlighting Hyderabad's appeal to global investors and its ...

HYDERABAD: Despite posting record revenues, pharma major Dr Reddy’s Laboratories on Thursday reported a marginal 2% increase in consolidated profit after tax (PAT attributable to equity holders) at Rs ...

Dr Reddy’s Laboratories’ net profit is likely to remain little lower or almost flat at around ₹1360-65 crore in the third quarter of the current fiscal ended December 2024 compared to ...

The ₹2,000-crore deal has since moved into advanced stages, with non-binding bids submitted by multiple players, including Dr. Reddy’s Laboratories and Zydus.

Dr. Reddy's net profit for the third quarter is expected to grow 10% YoY, with revenues likely increasing 13% YoY, based on an average of four brokerage estimates. US sales are projected to remain ...